SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

PACIARONI, Maurizio
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.958
NA - Nord America 1.756
EU - Europa 1.527
SA - Sud America 971
AF - Africa 118
OC - Oceania 28
Totale 7.358
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.589
SG - Singapore 1.252
BR - Brasile 801
HK - Hong Kong 597
CN - Cina 392
VN - Vietnam 342
IT - Italia 309
NL - Olanda 309
DE - Germania 149
GB - Regno Unito 121
CA - Canada 98
FR - Francia 93
RU - Federazione Russa 76
AR - Argentina 62
UA - Ucraina 59
EC - Ecuador 56
ZA - Sudafrica 55
ES - Italia 53
BE - Belgio 51
JP - Giappone 50
MX - Messico 48
AE - Emirati Arabi Uniti 46
BD - Bangladesh 46
AT - Austria 45
IN - India 44
PL - Polonia 41
FI - Finlandia 39
PT - Portogallo 39
ID - Indonesia 37
HU - Ungheria 30
SE - Svezia 30
EG - Egitto 28
TW - Taiwan 28
AU - Australia 27
IE - Irlanda 24
TR - Turchia 22
IQ - Iraq 19
PY - Paraguay 14
NO - Norvegia 12
UZ - Uzbekistan 12
CO - Colombia 11
MA - Marocco 11
LT - Lituania 10
PK - Pakistan 10
CH - Svizzera 8
IL - Israele 8
PE - Perù 8
CL - Cile 7
DZ - Algeria 7
KE - Kenya 7
SA - Arabia Saudita 6
AZ - Azerbaigian 5
JM - Giamaica 5
MY - Malesia 5
OM - Oman 5
TN - Tunisia 5
BO - Bolivia 4
BY - Bielorussia 4
CZ - Repubblica Ceca 4
DO - Repubblica Dominicana 4
HR - Croazia 4
JO - Giordania 4
KZ - Kazakistan 4
TH - Thailandia 4
UY - Uruguay 4
VE - Venezuela 4
AM - Armenia 3
CR - Costa Rica 3
NI - Nicaragua 3
NP - Nepal 3
RO - Romania 3
AL - Albania 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BG - Bulgaria 2
GE - Georgia 2
GR - Grecia 2
HN - Honduras 2
IR - Iran 2
LV - Lettonia 2
PA - Panama 2
PS - Palestinian Territory 2
RS - Serbia 2
AO - Angola 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BW - Botswana 1
CY - Cipro 1
DK - Danimarca 1
ET - Etiopia 1
GA - Gabon 1
KG - Kirghizistan 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LY - Libia 1
MD - Moldavia 1
NC - Nuova Caledonia 1
PH - Filippine 1
Totale 7.358
Salva come PNG Salva come JPEG
Città #
Hong Kong 594
Singapore 533
Ashburn 319
Dallas 155
Beijing 151
Ho Chi Minh City 117
Hanoi 93
Los Angeles 93
Amsterdam 84
São Paulo 68
New York 56
Utrecht 53
Chicago 51
Hefei 48
Tokyo 43
Warsaw 39
Groningen 38
Abu Dhabi 37
Lisbon 37
Quito 36
Bologna 35
Poplar 32
Budapest 28
Mulhouse 28
Nuremberg 28
De Lier 26
Stockholm 26
Barcelona 25
Lappeenranta 25
Mexico City 25
Cairo 23
Montreal 23
Belo Horizonte 22
Boardman 22
Orem 22
Taichung 22
Vancouver 22
Denver 21
Dublin 21
Paris 21
Rio de Janeiro 20
Salt Lake City 20
Santa Clara 20
Brooklyn 19
Milan 19
Falkenstein 18
Atlanta 17
Ferrara 17
Naaldwijk 17
Des Moines 16
Sydney 16
Curitiba 15
Dhaka 15
Haiphong 15
Guarulhos 14
Jakarta 14
Rome 14
Shanghai 14
Boston 13
Brasília 13
Da Nang 13
Johannesburg 13
Munich 13
Tampa 13
Winschoten 13
Woodbridge 13
Guayaquil 12
Moscow 12
Seattle 12
Frankfurt am Main 11
Houston 11
London 11
Phoenix 11
Porto Alegre 11
Tashkent 11
Vienna 11
Biên Hòa 10
Chennai 10
Derby 10
Fairfield 10
Madrid 10
Rotterdam 10
Toronto 10
Winnipeg 10
Bari 9
Cambridge 9
Florence 9
Hangzhou 9
Hải Dương 9
Querétaro 9
Salvador 9
Assago 8
Etobicoke 8
Manchester 8
Melbourne 8
Ninh Bình 8
Oslo 8
Panningen 8
San Francisco 8
Ankara 7
Totale 3.873
Salva come PNG Salva come JPEG
Nome #
2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) 912
Association Between Migraine and Cervical Artery Dissection The Italian Project on Stroke in Young Adults 116
Early vs Late Anticoagulation in Minor, Moderate, and Major Ischemic Stroke With Atrial Fibrillation: Post Hoc Analysis of the ELAN Randomized Clinical Trial 91
Direct Oral Anticoagulants Versus Warfarin in the Treatment of Cerebral Venous Thrombosis (ACTION-CVT): A Multicenter International Study 90
Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study 89
Exploring Sex Differences in Outcomes of Dual Antiplatelet Therapy for Patients With Noncardioembolic Mild-to-Moderate Ischemic Stroke or High-Risk Transient Ischemic Attack: A Propensity-Matched Analysis of the READAPT Study Cohort 79
Early seizures and risk of epilepsy and death after intracerebral haemorrhage: The MUCH Italy 78
Admission systolic blood pressure and short-term outcomes after dual antiplatelet therapy in patients with minor ischemic stroke or transient ischemic attack 74
Volume Tolerance and Prognostic Impact of Hematoma Expansion in Deep and Lobar Intracerebral Hemorrhage 73
Transient brain ischemic symptoms and the presence of ischemic lesions at neuroimaging – Results from the READAPT study 71
Long-Term Risk of Arterial Thrombosis After Intracerebral Hemorrhage: MUCH-Italy 63
Age- and sex-specific analysis of patients with embolic stroke of undetermined source 62
Long-term outcome of cervical artery dissection : IPSYS CeAD: study protocol, rationale, and baseline data of an Italian multicenter research collaboration 61
Stroke network performance during the first COVID-19 pandemic stage: A meta-analysis based on stroke network models 60
History of stroke 59
Safety and efficacy of concomitant treatment with non-vitamin K antagonist oral anticoagulants and antiseizure medications: A propensity score matching cohort study 59
Early Versus Late Initiation of Direct Oral Anticoagulants After Ischemic Stroke in People With Atrial Fibrillation and Hemorrhagic Transformation: Prespecified Subanalysis of the Randomized Controlled ELAN Trial 58
Treatments in Ischemic Stroke: Current and Future 58
Real-world comparison of dual versus single antiplatelet treatment in patients with non-cardioembolic mild-to-moderate ischemic stroke: A propensity matched analysis 58
Acute myocardial infarction and heart failure in acute stroke patients: frequency and influence on clinical outcome 56
Risk Profile of Patients with Spontaneous Cervical Artery Dissection 54
Anticoagulant vs. antiplatelet therapy in patients with cryptogenic stroke and patent foramen ovale: an individual participant dta meta-analysis 54
Divergence Between Clinical Trial Evidence and Actual Practice in Use of Dual Antiplatelet Therapy After Transient Ischemic Attack and Minor Stroke 54
The turning point in stroke investigation for neurologists 53
Statin use and long-term risk of recurrent intracerebral haemorrhage: the MUCH-Italy 53
15-Year Outcomes of PFO Closure in Patients With Cryptogenic Embolism: Insights From the PROLONG Registry 52
Left Atrial Appendage Occlusion vs Standard of Care After Ischemic Stroke Despite Anticoagulation 51
Timing of oral anticoagulants initiation for atrial fibrillation after acute ischemic stroke: A systematic review and meta-analysis 50
Acute hyperglycemia and early hemorrhagic transformation in ischemic stroke 50
Clinical Features of Patients With Cervical Artery Dissection and Fibromuscular Dysplasia 49
Beyond RCTs: Short-term dual antiplatelet therapy in secondary prevention of ischemic stroke and transient ischemic attack 49
Consensus paper on the management of acute isolated vertigo in the emergency department 49
Admission Leukocytosis in Acute Cerebral Ischemia: Influence on Early Outcome 48
Age-dependent effect of susceptibility factors on the risk of intracerebral haemorrhage: Multicenter Study on Cerebral Hemorrhage in Italy (MUCH-Italy) 48
Effectiveness and safety of dual antiplatelet therapy in patients with minor ischemic stroke or transient ischemic attack and cancer: A secondary analysis of the READAPT study 48
Antithrombotic therapy in the postacute phase of cervical artery dissection: the Italian Project on Stroke in Young Adults Cervical Artery Dissection 48
Prevalence of patent foramen ovale in ischemic stroke in Italy: the SISIFO study 48
Anticoagulation After Stroke in Patients With Atrial Fibrillation 48
96 hours ECGmonitoring for patients with ischemic cryptogenic stroke or transient ischaemicattack 47
Migraine improvement after spontaneous cervical artery dissection the Italian Project on Stroke in Young Adults (IPSYS) 47
History of cardiac embolism 47
[Multidisciplinary position paper on the management of patent foramen ovale in the presence of cryptogenic cerebral ischemia - Italian version 2013] 47
European Stroke Organisation (ESO) guideline on screening for subclinical atrial fibrillation after stroke or transient ischaemic attack of undetermined origin 46
A sudden neurological deficit in a patient with endocarditis 46
A case of typical headache with an atypical diagnosis 46
Investigational drugs for ischemic stroke: what's in the clinical development pipeline for acute phase and prevention? 45
Predictors of severe intracerebral hemorrhage expansion 45
A nomogram to predict unfavourable outcome in patients receiving oral anticoagulants for atrial fibrillation after stroke 45
The clinical spectrum of reversible cerebral vasoconstriction syndrome: The Italian Project on Stroke at Young Age (IPSYS) 45
Hypercoagulability State in Predicting Severe Functional Outcome in Patients with Acute Ischemic Stroke: Cause, Consequence, or Both? 45
Erratum to: Prevalence of patent foramen ovale in ischemic stroke in Italy: the SISIFO Study (Neurol Sci (2014) 35, (867-873), 10.1007/s10072-013-1615-2) 45
Migraine and Cryptogenic Ischemic Stroke 44
Timing and Predictors of Recanalization After Anticoagulation in Cerebral Venous Thrombosis 44
Hypertension, seizures, and epilepsy: a review on pathophysiology and management 44
Acute hematoma expansion after spontaneous intracerebral hemorrhage: risk factors and impact on long-term prognosis 44
Ischemic stroke while on NOAC therapy in patients with atrial fibrillation: suggested treatment strategies 44
Net Benefit of Early Anticoagulation for Stroke With Atrial Fibrillation: Post Hoc Analysis of the ELAN Randomized Clinical Trial 44
Outcome Prediction in Cerebral Venous Thrombosis: The IN-REvASC Score 43
The risk of stroke recurrence in patients with atrial fibrillation and reduced ejection fraction 43
Early versus Later Anticoagulation for Stroke with Atrial Fibrillation 43
Real-World Dual Antiplatelet Therapy Use Exceeds Randomized Trials Boundaries With Possible Safety Issues in Patients With Large Artery Atherosclerosis-Insights From the READAPT Study 42
Combining Intravenous Thrombolysis and Dual Antiplatelet Treatment in Patients With Minor Ischemic Stroke: A Propensity Matched Analysis of the READAPT Study Cohort 42
How lower doses of direct oral anticoagulants are interpreted in clinical practice: a national survey of the Italian Atherosclerosis, Thrombosis and Vascular Biology (ATVB) Study Group 42
Profilassi secondaria nel paziente con attacco ischemico transitorio o ictus aterotrombotico carotideo [Secondary prevention in patients with transient ischemic attack or stroke due to carotid atherosclerosis] 41
A tool to identify patients with embolic stroke of undetermined source at high recurrence risk 41
Medical versus neurosurgical treatment in ICH patients: a single center experience 41
Prevention of venous thromboembolism in acute spontaneous intracerebral haemorrhage: A survey of opinion 41
Defining short-term outcomes of minor ischemic stroke due to small artery occlusion in the era of dual antiplatelet treatment: A READAPT study sub-analysis 40
Angiographic findings of moyamoya vessels in a patient with rheumatoid arthritis 40
Anticoagulation in acute ischemic stroke patients with mechanical heart valves: To bridge or not with heparin. The ESTREM study 40
Thrombolysis after dabigatran reversal: A nation-wide Italian multicentre study, systematic review and meta-analysis 40
Functional outcome improvement from 3 to 12 months after intracerebral hemorrhage 40
Alcohol intake and the risk of intracerebral hemorrhage in the elderly: The MUCH-Italy 40
Early versus late start of direct oral anticoagulants after acute ischaemic stroke linked to atrial fibrillation: an observational study and individual patient data pooled analysis 40
Secondary stroke prevention in people with atrial fibrillation: treatments and trials 40
Characteristics of intracerebral hemorrhage associated with dual antiplatelet treatment 40
Effects of Direct Oral Anticoagulants' Nonrecommended Dose in Atrial Fibrillation: A Meta-Analysis 40
Outcomes and Recurrence Rates Among Patients With Provoked and Cryptogenic Cerebral Venous Thrombosis: Analysis of the ACTION CVT 38
Cerebral venous sinus thrombosis associated with cancer: analysis of the ACTION-CVT study 38
The Impact of Atherosclerotic Burden on Vascular Outcomes in Patients with Stroke and Atrial Fibrillation: The ATHENA study 38
Long-Term Risk of Recurrent Cervical Artery Dissection and Stroke After Pregnancy 38
Acute stroke treatment: thrombolysis 38
Recurrent Ischemic Stroke and Bleeding in Patients With Atrial Fibrillation Who Suffered an Acute Stroke While on Treatment With Nonvitamin K Antagonist Oral Anticoagulants: The RENO-EXTEND Study 37
Early versus Late initiation of direct oral Anticoagulants in post-ischaemic stroke patients with atrial fibrillatioN (ELAN): Protocol for an international, multicentre, randomised-controlled, two-arm, open, assessor-blinded trial 37
Comparative study of venous thromboembolic prophylaxis strategies in hemorrhagic stroke: A systematic review and network meta-analysis 37
Prolonged cardiac monitoring for stroke prevention: A systematic review and meta-analysis of randomized-controlled clinical trials 37
Acute stroke symptoms: Do differences exist between sexes? 36
Practical "1-2-3-4-Day" Rule for Starting Direct Oral Anticoagulants After Ischemic Stroke With Atrial Fibrillation: Combined Hospital-Based Cohort Study 36
Risk of Recurrent Stroke, Mortality, and Intracerebral Hemorrhage in Patients With Atrial Fibrillation Detected Before or After a Stroke 35
Susceptibility to brain ischemia and the association between migraine and spontaneous cervical artery dissection 34
Systemic thrombolysis in patients with acute stroke and active cancer: a systematic review and meta-analysis 34
Predictors of Recurrent Venous Thrombosis After Cerebral Venous Thrombosis: Analysis of the ACTION-CVT Study 34
Oral Anticoagulants in the Oldest Old with Recent Stroke and Atrial Fibrillation 32
Time trends, frequency, characteristics and prognosis of short-duration transient global amnesia 31
Characteristics and causes of recurrent ischemic events in minor ischemic stroke and TIA in the READAPT study 31
Anticoagulants Resumption after Warfarin-Related Intracerebral Haemorrhage: The Multicenter Study on Cerebral Hemorrhage in Italy (MUCH-Italy) 30
Long-Term Risk of Stroke After Transient Global Amnesia in Two Prospective Cohorts 30
Un caffè tra due amici al bar. L'esame obiettivo neurologico 30
Reduced Admissions for Cerebrovascular Events During COVID-19 Outbreak in Italy 30
Risk of recurrent stroke in patients with atrial fibrillation treated with oral anticoagulants alone or in combination with anti-platelet therapy 28
Totale 5.641
Salva come PNG Salva come JPEG
Categoria #
all - tutte 36.886
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.654
Totale 39.540
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202127 0 0 0 0 0 3 0 7 3 9 3 2
2021/202218 2 1 0 5 1 0 3 0 0 0 2 4
2022/20238 2 1 0 0 0 0 1 0 1 2 0 1
2023/20246 1 0 0 0 1 0 0 0 0 0 0 4
2024/20252.068 0 0 4 0 2 78 395 315 224 524 271 255
2025/20265.704 571 675 1.161 1.559 1.337 401 0 0 0 0 0 0
Totale 7.869